The HLA-DRB1*12:92 and HLA-DRB1*12:101 alleles were identified by next-generation sequencing.

Compared with HLA-DRB1*12:02, the alleles HLA-DRB1*12:92 and HLA-DRB1*12:101 each show one nucleotide substitution respectively.

Urbanization promotes carbon storage or not? The evidence during the rapid process of China.

China's commitment to attaining carbon neutrality by 2060 has galvanized research into carbon sequestration, a critical approach for mitigating climate change. Despite the rapid urbanization observed since the turn of the millennium, a comprehensive analysis of how urbanization influences urban carbon storage throughout China remains elusive. Our investigation delves into the nuanced effects of urbanization on carbon storage, dissecting both the direct and indirect influences by considering urban-suburban gradients and varying degrees of urban intensity. We particularly scrutinize the roles of climatic and anthropogenic factors in mediating the indirect effects of urbanization on carbon storage. Our findings reveal that urbanization in China has precipitated a direct reduction in carbon storage by approximately 13.89 Tg of carbon (Tg C). Remarkably, urban sprawl has led to a diminution of vegetation carbon storage by 8.65 Tg C and a decrease in soil carbon storage by 5.24 Tg C, the latter resulting from the sequestration of impervious surfaces and the elimination of organic matter inputs following vegetation removal. Meanwhile, carbon storage in urban greenspaces has exhibited an increase of 6.90 Tg C and offsetting 49.70% of the carbon loss induced by direct urbanization effects. However, the indirect effects of urbanization predominantly diminish carbon storage in urban greenspaces by an average of 5.40%. The degree of urban vegetation management emerges as a pivotal factor influencing the indirect effects of urbanization on carbon storage. To bolster urban carbon storage, curbing urban sprawl and augmenting urban green spaces are imperative strategies. Insights from this study are instrumental in steering sustainable urban planning and advancing towards the goal of carbon neutrality.

Identification of the novel HLA-DRB1*11:298 allele in a Chinese cord blood donor.

HLA-DRB1*11:298 shows one single nucleotide substitution at position 397 T>G compared with HLA-DRB1*11:01:01:01.

Synthesis of 2,2-difunctionalized 2H-azirines via I2-mediated annulation of enamines.

Various 2,2-difunctionalized 2H-azirines were synthesized via I2-mediated annulation reactions of readily accessible enamines in the presence of nitrogen or non-nitrogen nucleophiles. The features of the present synthesis process also include no use of transition metals, simple operation, mild reaction conditions, a broad substrate scope, and gram-scale synthesis.

Identification of the novel HLA-A*29:171 allele by next-generation sequencing.

HLA-A*29:171 differs from HLA-A*29:01:01:01 by one nucleotide substitution at position 257T>G in exon 2.

Full annotation of viral metagenomics in different components from Chinese blood donors using next-generation sequencing.

BACKGROUND: Emerging viruses in the blood of healthy/qualified donors can seriously affect transfusion safety. However, the virus characteristics in different healthy blood donors and blood components are still not fully understood. MATERIALS AND METHODS: Buffy coat (BC) and plasma specimens were collected from 32 whole blood donors, and platelet (PLT) and BC specimens from 30 apheresis platelet donors to explore the full annotation of viral metagenomics in different blood components from Chinese blood donors using next-generation sequencing technology. RESULTS: The study detected 56 viruses in the plasma and BC groups of whole blood donors. The plasma group had a significantly higher viral abundance and more types of viruses than the BC group. We detected 20 viruses in the PLT and BC groups of apheresis platelet donors. Viral abundance and types were significantly lower in the BC group than in the PLT group. According to ß-diversity analysis, the plasma group had a significantly different community structure and composition than the BC group. DISCUSSION: Viral nucleic acid is found in the blood of healthy Chinese blood donors, with the highest concentration in plasma, which could explain the distribution of viruses in the blood of healthy individuals.

Identification of the novel HLA-A*03:453 allele in a Chinese blood donor.

HLA-A*03:453 differs from HLA-A*03:02:01:01 by one single nucleotide substitution at position 376 G > A.

Description of the novel HLA allele, HLA-C*01:220 in a Chinese individual.

HLA-C*01:220 has one nucleotide change compared with HLA-C*01:02:01:01 in codon 163 of exon 3.

Description of two new HLA alleles, HLA-A*26:01:70 and HLA-A*26:01:74 in Chinese individuals.

Compared with HLA-A*26:01:01:01, the alleles HLA-A*26:01:70, and HLA-A*26:01:74 each show one nucleotide substitution, respectively.

Identification of the novel HLA-B*46:95N allele in a Chinese blood donor.

HLA-B*46:95N shows one nucleotide substitution at position 2 when compared with HLA-B*46:01:01:01.

Simultaneous genotyping for human platelet antigen systems and HLA-A and HLA-B loci by targeted next-generation sequencing.

In order to treat the alloimmunization platelet transfusion refractoriness (PTR), human leukocyte antigen (HLA)-type and/or human platelet antigen (HPA)-type matched platelets between donors and patients are usually used. Therefore, genotyping of HLA-A and HLA-B loci, as well as HPA systems, for donors and patients, is of great significance. However, there is a rare report of genotyping for HLA-A and HLA-B loci as well as HPA systems at the same time. In this study, a high-throughput method for simultaneous genotyping of HLA-A and HLA-B loci, as well as HPA genotyping, was developed. A RNA capture probe panel was designed covering all exon sequences of the GP1BA, GP1BB, ITGA2, CD109, ITGB3, and ITGA2B genes and HLA-A and HLA-B loci. The HLA-A, HLA-B, and 34 HPA systems were genotyped using a targeted next-generation sequencing (NGS) method. The genotypes of the HLA-A and HLA-B loci, as well as the HPA, were assigned based on the nucleotides in the polymorphism sites. Using the NGS method, 204 unrelated blood specimens were successfully genotyped for all 34 HPA systems as well as HLA-A and HLA-B loci. The accuracy of the NGS method was 100%. Only HPA-2, HPA-3, HPA-5, HPA-6w, HPA-15, and HPA-21w showed polymorphism with frequencies of 0.9412, 0.6863, 0.9853, 0.9779, 0.4314, and 0.9951 for a allele, respectively. Thirty-two single nucleotide variants (SNVs) were detected. Of them, 12 SNVs can lead to amino acid change. HLA-A*11:01 and HLA-B*46:01 are the most common alleles for HLA-A and HLA-B loci. A targeted next-generation sequencing method for simultaneously genotyping HPA systems and HLA-A and HLA-B loci was first established, which could be used to create a database of HLA-typed and/or HPA-typed unrelated donors.

Analysis of the Genomic Sequence of ABO Allele Using Next-Generation Sequencing Method.

Background: Although many molecular diagnostic methods have been used for ABO genotyping, there are few reports on the full-length genomic sequence analysis of the ABO gene. Recently, next-generation sequencing (NGS) has been shown to provide fast and high-throughput results and is widely used in the clinical laboratory. Here, we established an NGS method for analyzing the sequence of the start codon to the stop codon in the ABO gene. Study Design and Methods: Two pairs of primers covering the partial 5'-untranslated region (UTR) to 3'-UTR of the ABO gene were designed. The sequences covering from the start codon to the stop codon of the ABO gene were amplified using these primers, and an NGS method based on the overlap amplicon was developed. A total of 110 individuals, including 88 blood donors with normal phenotypes and 22 ABO subtypes, were recruited and analyzed. All these specimens were first detected by serological tests and then determined by polymerase chain reaction sequence-based typing (PCR-SBT) and NGS. The sequences, including all the intron regions for the specimens, were analyzed by bioinformatics software. Results: Among the 88 blood donors with a normal phenotype, 48 homozygous individuals, 39 heterozygous individuals, and one individual with a novel O allele were found according to the results of the PCR-SBT method. Some single-nucleotide variants (SNV) in intronic regions were found to be specific for different ABO alleles from 48 homozygous individuals using the NGS method. Sequences in the coding region of all specimens using the NGS method were the same as those of the PCR-SBT method. Three intronic SNVs were found to be associated with the ABO subtypes, including one novel intronic SNV (c.28+5956T>A). Moreover, six specimens were found to exhibit DNA recombination. Conclusion: An NGS method was established to analyze the sequence from the start codon to the stop codon of the ABO gene. Two novel ABO alleles were identified, and DNA recombination was found to exist in the ABO alleles.

The novel HLA-C allele, HLA-C*03:537 in a Chinese individual.

HLA-C*03:537 allele is identical to HLA-C*03:03:01:01 except for a single nucleotide substitution G257C.

The novel HLA-C allele, C*03:538 was identified by next-generation sequencing.

HLA-C*03:538 differs from HLA-C*03:04:01:01 by a mutation at nucleotide 920.

HLA-DRB1*15:01:43 and HLA-DRB1*15:01:44 alleles were identified by next-generation sequencing.

Compared with HLA-DRB1*15:01:01:01, the alleles HLA-DRB1*15:01:43 and HLA-DRB1*15:01:44 each show one nucleotide substitution respectively.

Characterization of the novel HLA-A*11:383N and HLA-A*11:388N alleles by next-generation sequencing.

Compared with HLA-A*11:01:01:01, the alleles HLA-A*11:383N, and HLA-A*11:388N each show one single nucleotide substitution.

The novel HLA-DRB1*15:01:42 allele was identified by next-generation sequencing.

HLA-DRB1*15:01:42 differs from HLA-DRB1*15:01:01:01 by one single nucleotide substitution at position 732 C>T.

Identification of the novel HLA-DRB1*11:271 allele by next-generation sequencing.

HLA-DRB1*11:271 differs from HLA-DRB1*11:01:01:01 by a single nucleotide substitution at position 610G > A.

Identification of the novel HLA-B*55:107 allele in a Chinese bone marrow donor.

HLA-B*55:107 shows two nucleotides substitution when compared to HLA-B*55:02:01:01.

[Study of the distribution of KIR3DL2 alleles among ethnic Han Chinese from Zhejiang].

OBJECTIVE: To study the distribution of KIR3DL2 alleles among ethnic Han Chinese from Zhejiang. METHODS: Genomic DNA was extracted by using a magnetic bead method. The full sequence of the KIR3DL2 gene was amplified with four pairs by PCR primers. The coding regions of 208 unrelated ethnic Han Chinese blood donors were analyzed using a BigDye Terminator v3.1 Sequencing Kit. The genotypes were assigned based on the nucleotide polymorphism of the KIR3DL2 gene. RESULTS: Among the 208 samples, 133 were KIR3DL2 heterozygotes and 75 were homozygotes. Forty six KIR3DL2 genotypes were detected. Respectively, 70, 33 and 23 individuals were found to have a KIR3DL2*00201/KIR3DL2*00201, KIR3DL2*00201/KIR3DL2*00701, and KIR3DL2*00201/KIR3DL2*01001 genotype. Twenty-two KIR3DL2 alleles were discovered, and the frequencies of KIR3DL2*00201, KIR3DL2*00701 and KIR3DL2*01001 were 57.45%, 13.46% and 9.13%, respectively. CONCLUSION: The distribution of KIR3DL2 alleles among ethnic Han Chinese in Zhejiang has been determined and fits the criteria for genetic polymorphism.